• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

酮色林对原发性雷诺现象患者的急性效应及作用机制

Acute effects and mechanism of action of ketanserin in patients with primary Raynaud's phenomenon.

作者信息

Brouwer R M, Wenting G J, Schalekamp M A

机构信息

Department of Internal Medicine I, University Hospital Rotterdam Dijkzigt, The Netherlands.

出版信息

J Cardiovasc Pharmacol. 1990 Jun;15(6):868-76. doi: 10.1097/00005344-199006000-00003.

DOI:10.1097/00005344-199006000-00003
PMID:1694908
Abstract

This study evaluates the vasoactive effects and mode of action of ketanserin, a selective 5HT2 receptor antagonist, on digital circulation in 11 patients with primary Raynaud's phenomenon. Reflex digital vasoconstriction was induced by moderate body cooling. We found that ketanserin given intravenously in a dose of 10 mg, normalized digital skin temperature and digital blood flow as estimated by venous occlusion plethysmography and laser-Doppler flowmetry. However, effects of ketanserin on transcutaneously measured oxygen pressure were modest. This could imply a preferential effect of ketanserin on arteriovenous shunt flow. Pretreatment with high doses of the selective and nonselective alpha-adrenoreceptor antagonists prazosin and phentolamine did not abolish the effects of ketanserin on digital blood flow. However, under alpha-adrenoceptor blockade the small effects of ketanserin on normal blood pressure disappeared. Thus, in contrast to the effects in the systemic circulation, the principal mechanism underlying digital vasodilation after ketanserin is unlikely to involve alpha-adrenoceptor antagonism. We conclude that 5HT2 receptors are present in the digital vasculature. In patients with primary Raynaud's phenomenon, their activation plays an important role in cold-induced digital vasoconstriction.

摘要

本研究评估了选择性5-羟色胺2(5HT2)受体拮抗剂酮色林对11例原发性雷诺现象患者手指循环的血管活性作用及作用方式。通过适度降低体温诱发手指反射性血管收缩。我们发现,静脉注射10毫克酮色林可使手指皮肤温度以及通过静脉阻断体积描记法和激光多普勒血流仪估算的手指血流量恢复正常。然而,酮色林对经皮测量的氧分压影响不大。这可能意味着酮色林对动静脉分流血流具有优先作用。用高剂量的选择性和非选择性α-肾上腺素能受体拮抗剂哌唑嗪和酚妥拉明预处理并不能消除酮色林对手指血流量的影响。然而,在α-肾上腺素能受体阻断情况下,酮色林对正常血压的微小影响消失了。因此,与在体循环中的作用不同,酮色林后手指血管舒张的主要机制不太可能涉及α-肾上腺素能受体拮抗作用。我们得出结论,手指血管系统中存在5HT2受体。在原发性雷诺现象患者中,其激活在寒冷诱发的手指血管收缩中起重要作用。

相似文献

1
Acute effects and mechanism of action of ketanserin in patients with primary Raynaud's phenomenon.酮色林对原发性雷诺现象患者的急性效应及作用机制
J Cardiovasc Pharmacol. 1990 Jun;15(6):868-76. doi: 10.1097/00005344-199006000-00003.
2
Role of digital artery adrenoceptors in Raynaud's disease.数字动脉肾上腺素能受体在雷诺病中的作用。
Vasc Med. 1997;2(1):1-7. doi: 10.1177/1358863X9700200101.
3
Treatment of Raynaud's phenomenon with the 5-HT2-receptor antagonist ketanserin.使用5-羟色胺2受体拮抗剂酮色林治疗雷诺现象。
Br Med J (Clin Res Ed). 1982 Oct 16;285(6348):1069-71. doi: 10.1136/bmj.285.6348.1069.
4
Mechanism of action of ketanserin in hypertension and vasospastic disease.酮色林在高血压和血管痉挛性疾病中的作用机制。
Acta Cardiol. 1987;42(5):339-54.
5
Effect of long-term ketanserin treatment on 5-HT levels, platelet aggregation and peripheral circulation in patients with Raynaud's phenomenon. A double-blind, placebo-controlled cross-over study.长期服用酮色林对雷诺现象患者5-羟色胺水平、血小板聚集及外周循环的影响。一项双盲、安慰剂对照的交叉研究。
Int Angiol. 1988 Jan-Mar;7(1):19-25.
6
Role of alpha-adrenergic blockade in the cardiovascular actions of ketanserin: studies in patients with essential hypertension, autonomic insufficiency, and Raynaud's phenomenon.α-肾上腺素能阻滞在酮色林心血管作用中的角色:对原发性高血压、自主神经功能不全及雷诺现象患者的研究
J Cardiovasc Pharmacol. 1987;10 Suppl 3:S26-31.
7
Effect of ketanserin on Raynaud's phenomenon in progressive systemic sclerosis: a double-blind trial.酮色林对进行性系统性硬化症中雷诺现象的影响:一项双盲试验。
Drugs Exp Clin Res. 1985;11(9):659-63.
8
Treatment of Raynaud's phenomenon with ketanserin, a selective antagonist of the serotonin2 (5-HT2) receptor.用酮色林(一种5-羟色胺2(5-HT2)受体的选择性拮抗剂)治疗雷诺现象。
Arthritis Rheum. 1984 Feb;27(2):139-46. doi: 10.1002/art.1780270204.
9
The use of the selective serotonin S2 receptor antagonist Ketanserin in the treatment of Raynaud's phenomenon.选择性5-羟色胺S2受体拮抗剂酮色林在雷诺现象治疗中的应用。
Eur J Vasc Surg. 1988 Dec;2(6):371-5. doi: 10.1016/s0950-821x(88)80014-8.
10
Does serotonin receptor blockade have a therapeutic effect in Raynaud's phenomenon?血清素受体阻断对雷诺现象有治疗作用吗?
Vasa Suppl. 1987;18:64-7.

引用本文的文献

1
Higenamine exerts an antispasmodic effect on cold-induced vasoconstriction by regulating the PI3K/Akt, ROS/α2C-AR and PTK9 pathways independently of the AMPK/eNOS/NO axis.去甲乌药碱通过独立于AMPK/eNOS/NO轴调节PI3K/Akt、ROS/α2C-AR和PTK9途径,对冷诱导的血管收缩发挥解痉作用。
Exp Ther Med. 2019 Aug;18(2):1299-1308. doi: 10.3892/etm.2019.7656. Epub 2019 Jun 10.
2
Quantifying digital vascular disease in patients with primary Raynaud's phenomenon and systemic sclerosis.量化原发性雷诺现象和系统性硬化症患者的数字血管疾病。
Ann Rheum Dis. 1998 Feb;57(2):70-8. doi: 10.1136/ard.57.2.70.
3
Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease.
酮色林。对其药效学和药代动力学特性以及在高血压和外周血管疾病中的治疗潜力的综述。
Drugs. 1990 Dec;40(6):903-49. doi: 10.2165/00003495-199040060-00010.